How does fondaparinux work?

Fondaparinux (Arixtra®) differs from standard heparin and LMWH in several ways. In particular, it does not come from animal sources. Instead, this drug is a synthetic version of the active site of the heparin molecule and is an even smaller molecule than LMWH. Heparin blocks both thrombin and factor Xa, whereas LMWH has relatively more activity against factor Xa and relatively less activity against thrombin. By contrast, fondaparinux acts exclusively against factor Xa—it does not affect thrombin. Fondaparinux does not require monitoring.

Current News

Johns Hopkins All Children’s Hospital Named Nation’s First Pediatric National Blood Clot Alliance VTE Center of Excellence™

A new national benchmark in pediatric venous thromboembolism (VTE) care St. Petersburg, FL – The National Blood Clot Alliance (NBCA)…

Vein and Vascular Institute Named Nation’s First National Blood Clot Alliance Community DVT Excellence Center 

FOR IMMEDIATE RELEASE Voorhees, NJ – The National Blood Clot Alliance (NBCA) is proud to announce the designation of Vein and…